Protease activities are known to be critical in the pathogenesis of a wide variety of diseases including cancer, cardiovascular disease, and inflammatory and infectious diseases. Although large-scale efforts are providing valuable information regarding the expression of many diverse proteases in normal and disease tissues, these methods do not report the functional activity of proteases. Protease beacons are emerging as a powerful tool to non-invasively measure protease activity in vivo, and will benefit from approaches that enable more selective cleavage by individual targeted proteases and probe retention at the site of activation. This project aims to validate a generic molecular probe design to detect, localize, and quantify protease activities in vivo in normal and pathologic tissues and whole organisms. Specifically, a new class of protease activity probes will be created that exhibit the desired characteristics of high tissue uptake, selective activation by individual target proteases, and accumulation at sites of activation. The utility of these probes for the localization and quantification of protease activities in vivo will be demonstrated in normal mice and the ApoE(-/-) mouse model of atherosclerosis. Completion of this project will yield probes that accurately and reliably report the activity of proteases involved in normal and pathologic processes, with high potential for translational to humans. More generally, successful completion of the aims of this proposal will open the door to the measurement and localization of a wide range of protease activities in living organisms with high spatial and temporal precision.

Public Health Relevance

This project aims to enable the detection, localization and quantification of a large class of enzymes that play key roles in disease processes, to enable completely new therapeutic approaches and diagnostic tools. We will develop and validate molecular probes that enable measurement of two protease activities that play crucial roles in the progression of cardiovascular disease. !

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Research Project (R01)
Project #
Application #
Study Section
Clinical Molecular Imaging and Probe Development (CMIP)
Program Officer
Gerratana, Barbara
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California Santa Barbara
Engineering (All Types)
Biomed Engr/Col Engr/Engr Sta
Santa Barbara
United States
Zip Code
Guerrero, Jennifer L; O'Malley, Michelle A; Daugherty, Patrick S (2016) Intracellular FRET-based Screen for Redesigning the Specificity of Secreted Proteases. ACS Chem Biol 11:961-70
Shropshire, Tyler D; Reifert, Jack; Rajagopalan, Sridharan et al. (2014) Amyloid ? peptide cleavage by kallikrein 7 attenuates fibril growth and rescues neurons from A?-mediated toxicity in vitro. Biol Chem 395:109-18
Erster, Oran; Thomas, Jerry M; Hamzah, Juliana et al. (2012) Site-specific targeting of antibody activity in vivo mediated by disease-associated proteases. J Control Release 161:804-12
Jabaiah, Abeer M; Getz, Jennifer A; Witkowski, Witold A et al. (2012) Identification of protease exosite-interacting peptides that enhance substrate cleavage kinetics. Biol Chem 393:933-41